BEAMSTART Logo

Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’

Forbes LogoForbes17h ago

Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’ - Forbes

Quick Summary:

But it’s a pipe dream unless scientists are able to crack the code of one of the world’s sneakiest viruses.

The U.N.has proposed a target of ending AIDS by 2030.

More Pictures

Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’ - Forbes (Picture 1)

or

Article Details

Category: StartupsTechnology

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-07-23 @ 06:30:00 (17 hours ago)

News Timezone: GMT -5:00

News Source URL: forbes.com

Language: English

Article Length: 32 words

Reading Time: 1 minutes read

Sentences: 52 lines

Sentence Length: 1 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Forbes

News ID: 21749417

View Article Analysis

About Forbes

Forbes Logo

Main Topics: StartupsTechnology

Official Website: forbes.com

Update Frequency: 51 posts per day

Year Established: 1917

Headquarters: United States

News Last Updated: 12 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #40

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’" has 32 words across 52 sentences, which will take approximately 1 minutes for the average person to read.

Which news outlet covered this story?

The story "Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’" was covered 17 hours ago by Forbes, a news publisher based in United States.

How trustworthy is 'Forbes' news outlet?

Forbes is a fully independent (privately-owned) news outlet established in 1917 that covers mostly startups and technology news.

The outlet is headquartered in United States and publishes an average of 51 news stories per day.

It's most recent story was published 12 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #21749417
  • URL: https://beamstart.com/news/despite-gileads-promising-hiv-prevention-172173072

More News from Forbes

Latest Jobs

More Startups News

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

Our Company

© Copyright 2024 BEAMSTART. All Rights Reserved.